BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11798191)

  • 1. Microarray analysis of gene expression changes in mouse liver induced by peroxisome proliferator- activated receptor alpha agonists.
    Yamazaki K; Kuromitsu J; Tanaka I
    Biochem Biophys Res Commun; 2002 Jan; 290(3):1114-22. PubMed ID: 11798191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor alpha agonists increase nitric oxide synthase expression in vascular endothelial cells.
    Goya K; Sumitani S; Xu X; Kitamura T; Yamamoto H; Kurebayashi S; Saito H; Kouhara H; Kasayama S; Kawase I
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):658-63. PubMed ID: 14751809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor alpha (PPARalpha) agonists down-regulate alpha2-macroglobulin expression by a PPARalpha-dependent mechanism.
    González MC; Corton JC; Cattley RC; Herrera E; Bocos C
    Biochimie; 2009 Aug; 91(8):1029-35. PubMed ID: 19497347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood glucose-lowering nuclear receptor agonists only partially normalize hepatic gene expression in db/db mice.
    Loffler M; Bilban M; Reimers M; Waldhäusl W; Stulnig TM
    J Pharmacol Exp Ther; 2006 Feb; 316(2):797-804. PubMed ID: 16260581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisomal-proliferator-activated receptor alpha activates transcription of the rat hepatic malonyl-CoA decarboxylase gene: a key regulation of malonyl-CoA level.
    Lee GY; Kim NH; Zhao ZS; Cha BS; Kim YS
    Biochem J; 2004 Mar; 378(Pt 3):983-90. PubMed ID: 14641110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fenofibrate modulates cardiac and hepatic metabolism and increases ischemic tolerance in diet-induced obese mice.
    Aasum E; Khalid AM; Gudbrandsen OA; How OJ; Berge RK; Larsen TS
    J Mol Cell Cardiol; 2008 Jan; 44(1):201-9. PubMed ID: 17931655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver gene expression in rats in response to the peroxisome proliferator-activated receptor-alpha agonist ciprofibrate.
    Yadetie F; Laegreid A; Bakke I; Kusnierczyk W; Komorowski J; Waldum HL; Sandvik AK
    Physiol Genomics; 2003 Sep; 15(1):9-19. PubMed ID: 12851464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelin-1-induced cardiac hypertrophy is inhibited by activation of peroxisome proliferator-activated receptor-alpha partly via blockade of c-Jun NH2-terminal kinase pathway.
    Irukayama-Tomobe Y; Miyauchi T; Sakai S; Kasuya Y; Ogata T; Takanashi M; Iemitsu M; Sudo T; Goto K; Yamaguchi I
    Circulation; 2004 Feb; 109(7):904-10. PubMed ID: 14967736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptor alpha (PPARalpha) activators induce hepatic farnesyl diphosphate synthase gene expression in rodents.
    Le Jossic-Corcos C; Pastori GM; Duclos S; Kawabe Y; Pineau T; Bournot P
    J Steroid Biochem Mol Biol; 2004 Feb; 88(2):203-11. PubMed ID: 15084352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PPARalpha agonists reduce 11beta-hydroxysteroid dehydrogenase type 1 in the liver.
    Hermanowski-Vosatka A; Gerhold D; Mundt SS; Loving VA; Lu M; Chen Y; Elbrecht A; Wu M; Doebber T; Kelly L; Milot D; Guo Q; Wang PR; Ippolito M; Chao YS; Wright SD; Thieringer R
    Biochem Biophys Res Commun; 2000 Dec; 279(2):330-6. PubMed ID: 11118287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice.
    Berthou L; Duverger N; Emmanuel F; Langouët S; Auwerx J; Guillouzo A; Fruchart JC; Rubin E; Denèfle P; Staels B; Branellec D
    J Clin Invest; 1996 Jun; 97(11):2408-16. PubMed ID: 8647932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of cytochrome P-450 gene expression in endotoxemic mice is tissue specific and peroxisome proliferator-activated receptor-alpha dependent.
    Barclay TB; Peters JM; Sewer MB; Ferrari L; Gonzalez FJ; Morgan ET
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1250-7. PubMed ID: 10454501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptor-alpha regulates postischemic liver injury.
    Okaya T; Lentsch AB
    Am J Physiol Gastrointest Liver Physiol; 2004 Apr; 286(4):G606-12. PubMed ID: 14615282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor subtype-specific regulation of hepatic and peripheral gene expression in the Zucker diabetic fatty rat.
    Dana SL; Hoener PA; Bilakovics JM; Crombie DL; Ogilvie KM; Kauffman RF; Mukherjee R; Paterniti JR
    Metabolism; 2001 Aug; 50(8):963-71. PubMed ID: 11474486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor alpha is involved in the regulation of lipid metabolism by ginseng.
    Yoon M; Lee H; Jeong S; Kim JJ; Nicol CJ; Nam KW; Kim M; Cho BG; Oh GT
    Br J Pharmacol; 2003 Apr; 138(7):1295-302. PubMed ID: 12711630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reciprocal and coordinate regulation of serum amyloid A versus apolipoprotein A-I and paraoxonase-1 by inflammation in murine hepatocytes.
    Han CY; Chiba T; Campbell JS; Fausto N; Chaisson M; Orasanu G; Plutzky J; Chait A
    Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1806-13. PubMed ID: 16709944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential gene expression in mouse primary hepatocytes exposed to the peroxisome proliferator-activated receptor alpha agonists.
    Guo L; Fang H; Collins J; Fan XH; Dial S; Wong A; Mehta K; Blann E; Shi L; Tong W; Dragan YP
    BMC Bioinformatics; 2006 Sep; 7 Suppl 2(Suppl 2):S18. PubMed ID: 17118139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of allergen-induced airway inflammation and immune response by the peroxisome proliferator-activated receptor-alpha agonist fenofibrate.
    Delayre-Orthez C; Becker J; Auwerx J; Frossard N; Pons F
    Eur J Pharmacol; 2008 Feb; 581(1-2):177-84. PubMed ID: 18096152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, reduces hepatic steatosis and lipid peroxidation in fatty liver Shionogi mice with hereditary fatty liver.
    Harano Y; Yasui K; Toyama T; Nakajima T; Mitsuyoshi H; Mimani M; Hirasawa T; Itoh Y; Okanoue T
    Liver Int; 2006 Jun; 26(5):613-20. PubMed ID: 16762007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of peroxisome proliferator-activated receptor activators on the mRNA levels of genes involved in lipid metabolism in primary human monocyte-derived macrophages.
    Cabrero A; Cubero M; Llaverías G; Jové M; Planavila A; Alegret M; Sánchez R; Laguna JC; Carrera MV
    Metabolism; 2003 May; 52(5):652-7. PubMed ID: 12759900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.